Balchem Corporation's Participation in Notable Industry Conference

Author: Evelyn Baker Updated: 10-30-2025 09:23 AM

Balchem Corporation's Upcoming Conference Presentation

Balchem Corporation (NASDAQ: BCPC), a leader in specialty ingredients geared towards health and nutrition, is set to take the stage at a significant annual industrial conference. The announcement came on October 30, 2025, engaging industry professionals and stakeholders alike.

Key Participants at the Conference

Representing Balchem will be Ted Harris, the esteemed Chairman of the Board, alongside Martin Bengtsson, the Chief Financial Officer, and Allison Baurichter, the Senior Director of Investor Relations. Their participation signifies the company's commitment to sharing insights about its innovative approach and strategic direction with a broader audience.

About Balchem Corporation

Balchem Corporation has carved a niche for itself in the arena of specialty ingredient manufacturing. With a focus on enhancing the health and well-being of individuals globally, Balchem develops a diverse array of products that serve various sectors. Their commitment to quality and innovation defines their operations across three distinct business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Human Nutrition & Health Segment

The Human Nutrition & Health segment is dedicated to creating customized ingredient systems and key nutrients that cater to food, supplement, and pharmaceutical industries. Balchem's innovative solutions ensure that their products are not only effective but also aligned with the evolving needs of health-conscious consumers.

Animal Nutrition & Health Segment

As part of its robust offerings, Balchem provides specialized products tailored for the animal health sector. This segment focuses on enhancing the nutritional quality of animal feed, thereby contributing to the wellbeing of livestock and pets. Through its dedication to research and quality assurance, Balchem has established itself as a trusted partner in the animal nutrition marketplace.

Specialty Products Division

In addition to its health-focused segments, Balchem's Specialty Products division manufactures specialty-packaged chemicals aimed at various industries. This includes chelated minerals designed to meet the needs of the micronutrient agricultural sector, bridging the gap between performance and quality. Balchem’s ability to deliver specialized solutions has made it a preferred choice for many clients.

Contact Information

For more information, please reach out to Jacqueline Yarmolowicz at Balchem Corporation. For inquiries, you can call 845-326-5600. The dedicated team is eager to assist with any questions regarding their innovative product offerings and the recent conference engagement.

Frequently Asked Questions

What is Balchem Corporation known for?

Balchem Corporation is recognized for its development and manufacturing of specialty ingredients that enhance health and nutrition across various markets.

Who are the key speakers at the conference?

The conference will feature Ted Harris, Martin Bengtsson, and Allison Baurichter representing Balchem Corporation.

What segments does Balchem operate in?

Balchem operates in Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, providing a range of innovative solutions.

How can I contact Balchem Corporation?

You can contact Balchem Corporation by reaching out to Jacqueline Yarmolowicz or by calling 845-326-5600.

Why is the conference important for Balchem?

The conference provides Balchem a platform to showcase their innovations, connect with industry stakeholders, and share insights on health and nutrition advancements.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.